Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker

Figure 2

TK1 activity and protein levels in sera from MDS patients and blood donors. (A) STK1 activity in sera from blood donors (•) and MDS patients (■). (B) Concentrations of STK1 in sera from blood donors (•) and MDS patients (■). Error bars denote SDs. (C) The receiver operating characteristic (ROC) curve of STK1 activities for discrimination between blood donors and MDS patients. (D) ROC curve analysis of STK1 protein levels in blood donors and MDS patients.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us